Biolife Solutions (BLFS) Non-Current Assets (2010 - 2026)

Biolife Solutions (BLFS) has reported Non-Current Assets for 17 consecutive years, with $312.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Assets rose 19.28% year-over-year to $312.3 million in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 4.3% increase from a year earlier, with the FY2025 full-year figure at $269.3 million, up 7.42% from the prior year.
• Non-Current Assets was $312.3 million for Q2 2026 at Biolife Solutions, up from $267.7 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $425.3 million in Q1 2022 and troughed at $250.7 million in Q4 2024.
• A 5-year average of $300.8 million and a median of $292.2 million in 2023 frame the typical range for Non-Current Assets.
• The widest YoY moves for Non-Current Assets: up 244.43% in 2022, down 27.19% in 2022.
• Over 5 years, Non-Current Assets stood at $311.8 million in 2022, then fell by 6.31% to $292.1 million in 2023, then dropped by 14.17% to $250.7 million in 2024, then grew by 7.42% to $269.3 million in 2025, then gained by 15.96% to $312.3 million in 2026.
• The last three Non-Current Assets figures came in at $312.3 million (Q2 2026), $267.7 million (Q1 2026), and $269.3 million (Q4 2025), per Business Quant data.